24149-05-1

Usage

Uses

γ-Linolenyl Alcohol is an inhibitor of African swine fever virus. An antiviral agent.

InChI:InChI=1/C18H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h6-7,9-10,12-13,19H,2-5,8,11,14-18H2,1H3/b7-6-,10-9-,13-12-

Upstream product

• 506-26-3 all-cis-6,9,12-octadecatrienoic acid 
• 301-00-8 methyl linolenate 
• 1243300-25-5 C₂₃H₃₈O₄ 

Downstream Products

• 60187-52-2 γ-linolenyl mesylate 
• 25226-26-0 (6Z,9Z,12Z)-octadeca-6,9,12-trien-1-yl 4-methylbenzenesulfonate 
• 7324-41-6 cis-8,11,14-eicosatrienoic acid 

Relevant academic research and scientific papers

PROCESS FOR PREPARING AND PURIFYING FATTY ACIDS

There is provided a process for purifying a fatty acid, which process comprises reacting a fatty acid with a lithium salt in a first solution and under conditions to allow formation of a precipitate of a lithium salt of the fatty acid; isolating the precipitate; dissolving the precipitate in a second solution followed by separation of the organic and aqueous layers so formed; and evaporating the organic layer to isolate the purified fatty acid. There is also provided a process for increasing the length of a fatty acid, and the use of a lithium salt to purify a fatty acid.

Chemical synthesis of deuterium-labeled and unlabeled very long chain polyunsaturated fatty acids

First syntheses of a deuterium-labeled very long C34-containing polyunsaturated fatty acid, 34:5n5, and three other unlabeled very long chain C30-32 containing polyunsaturated fatty acids are reported. These syntheses were achieved by coupling chemically

Optimization of synthetic conditions for the preparation of dihomo-γ-linolenic acid from γ-linolenic acid

Orthogonal experiments were employed to optimize the correlated parameters of reduction, sulfonation, substitution and hydrolysis. These reactions were used to convert γ-linolenic acids into dihomo-γ-linolenic acids (DGLA). For the reduction, the best rea

New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain

N-Arachidonoylserotonin (AA-5-HT, 1a) is an inhibitor of fatty acid amide hydrolase (FAAH) that acts also as an antagonist of transient receptor potential vanilloid-type 1 (TRPV1) channels and is analgesic in rodents. We modified the chemical structure of 1a with the aim of developing "hybrid" FAAH/TRPV1 blockers more potent than the parent compound or obtaining analogues with single activity at either of the two targets to study the mechanism of the analgesic action of 1a. Thirty-eight AA-5-HT analogues, containing a serotonin "head" bound to a variety of lipophilic moieties via amide, urea, or carbamate functionalities, were synthesized. Unlike 1a, most of the new compounds possessed activity at only one of the two considered targets. The amides 1b and 1c of α- and γ-linolenic acid, however, showed "hybrid" activity similar to 1a. The carbamate 3f (OMDM106), although unable to antagonize TRPV1 receptors, was the most potent FAAH inhibitor in this study (IC50 = 0.5 μM). Compounds 3f and 1m (OMDM129), which exhibited activity at only FAAH or TRPV1, respectively, were 10-fold less potent than 1a at preventing formalin-induced hyperalgesia in mice.

Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and Cdc25B inhibition

Selective inhibitors of protein tyrosine phosphatases (PTPs) and dual-specificity phosphatases (DSPs) are expected to be useful tools for clarifying the biological functions of the PTPs themselves and also to be candidates for novel therapeutics. We planned a library approach for the identification of PTP/DSP inhibitors in which 3-acyltetronic acid is used as a "core" phosphate mimic. A series of novel tetronic acid derivatives were synthesized and evaluated as inhibitors of the dual-specificity protein phosphatases VHR and cdc25B. Several compounds are found to be potent inhibitors of cdc25B, which is a key enzyme for cell-cycle progression. The promising results described herein strongly indicated that this tetronic acid library is potent as a library focused on the PTP/DSP-selective inhibitor.

8,12-Dialkyl-PGE, and PGF1α

Prostaglandins E1 -type and F1 -type compounds of the formula EQU1 wherein R is hydrogen or a hydrocarbyl group containing from 1 to 12 carbon atoms, inclusive, wherein W is EQU2 or O =, wherein R7, R8, R9, R10, R11, R12, R13, and R14 are hydrogen or alkyl of 1 to 4 carbon atoms, inclusive, provided (1) that at least one of R7, R8, R9, R10, R11, R12, R13, and R14 is alkyl (2) that when R13 is alkyl, at least one of R7, R8, R9, R10, R11, R12, and R14 is alkyl, and (3) that when R7 is alkyl or thwn R7 and R8 are alkyl, at least one of R9, R10, R11, R12, R13, and R14 is alkyl; and the enantiomers and racemic mixtures thereof. These are useful for the same pharmacological purposes as the unsubstituted prostaglandins.